ICI 169,369 Selectively Blocks 5-Hydroxytryptamine2 Receptors and Lowers Portal Pressure in Portal Hypertensive Rats

This publication has 17 references indexed in Scilit:

• Comparison of the hemodynamic responses to ketanserin and prazosin in portal hypertensive rats
  Hepatology, 1988
• In vitro studies with ICI 169,369, a chemically novel 5-HT antagonist
  European Journal of Pharmacology, 1988
• Beneficial hemodynamic effects of ketanserin in patients with cirrhosis: Possible role of serotonergic mechanisms in portal hypertension
  Hepatology, 1987
• Hypersensitivity of mesenteric veins to 5‐hydroxytryptamine‐ and ketanserin‐induced reduction of portal pressure in portal hypertensive rats
  British Journal of Pharmacology, 1986
• Increased Portal Venous Resistance Hinders Portal Pressure Reduction During the Administration of β–Adrenergic Blocking Agents in A Portal Hypertensive Model
  Hepatology, 1985
• 5HT2 receptors in the rat portal vein: Desensitization following cumulative serotonin addition
  Life Sciences, 1984
• Interaction of ketanserin and its metabolite ketanserinol with 5HT2 receptors in pulmonary and coronary arteries of calf
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1984
• Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension.
  Gut, 1984
• Mechanism of the Hypotensive Effect of Ketanserin
  Journal of Cardiovascular Pharmacology, 1982
• Organ blood flow measured with microspheres in the unanesthetized rat: Effects of three room temperatures
  Journal of Pharmacological Methods, 1978